Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 11Adenocarcinoma of Lung 4Rectal Neoplasms 3Triple Negative Breast Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Neoplastic Cells, Circulating 1Lymphedema 1Lung Neoplasms 1Carcinoma, Lobular 1Carcinoma, Intraductal, Noninfiltrating 1Carcinoma, Ductal, Breast 1

Interventions

Manual Lymphatic Drainage 2Exercise 2Weights and Measures 1Ultrasonography 1Tocopherols 1Standard of Care 1Resistance Training 1Range of Motion, Articular 1Pravastatin 1Phenoxybenzamine 1Pharmaceutical Preparations 1Pentoxifylline 1Operative Blood Salvage 1Myofascial Release Therapy 1Mastectomy, Segmental 1Mastectomy 1Lymphoscintigraphy 1Low-Level Light Therapy 1Ketoprofen 1High-Energy Shock Waves 1Diffusion Tensor Imaging 1Control Groups 1Bupivacaine 1Body Mass Index 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Lymphedema × Mastectomy, Segmental × Clear all
NCT06092892 2026-05-11

IIT2023-09-Chung-UpfrontTAD: Upfront TAD/SNB in Patients With Breast Cancer With Nodal Metastases

Cedars-Sinai Medical Center

Phase 2 Recruiting
45 enrolled
Breast

Breast Neoplasms, Lymphedema

Data powered by HemOnc (CC BY 4.0) Colophon âš¡